FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2617221282> ?p ?o ?g. }

• W2617221282 endingPage "11153" @default.
• W2617221282 startingPage "11147" @default.
• W2617221282 abstract "NAD+ biosynthesis is an attractive and promising therapeutic target for influencing health span and obesity-related phenotypes as well as tumor growth. Full and effective use of this target for therapeutic benefit requires a complete understanding of NAD+ biosynthetic pathways. Here, we report a previously unrecognized role for a conserved phosphoribosyltransferase in NAD+ biosynthesis. Because a required quinolinic acid phosphoribosyltransferase (QPRTase) is not encoded in its genome, Caenorhabditis elegans are reported to lack a de novo NAD+ biosynthetic pathway. However, all the genes of the kynurenine pathway required for quinolinic acid (QA) production from tryptophan are present. Thus, we investigated the presence of de novo NAD+ biosynthesis in this organism. By combining isotope-tracing and genetic experiments, we have demonstrated the presence of an intact de novo biosynthesis pathway for NAD+ from tryptophan via QA, highlighting the functional conservation of this important biosynthetic activity. Supplementation with kynurenine pathway intermediates also boosted NAD+ levels and partially reversed NAD+-dependent phenotypes caused by mutation of pnc-1, which encodes a nicotinamidase required for NAD+ salvage biosynthesis, demonstrating contribution of de novo synthesis to NAD+ homeostasis. By investigating candidate phosphoribosyltransferase genes in the genome, we determined that the conserved uridine monophosphate phosphoribosyltransferase (UMPS), which acts in pyrimidine biosynthesis, is required for NAD+ biosynthesis in place of the missing QPRTase. We suggest that similar underground metabolic activity of UMPS may function in other organisms. This mechanism for NAD+ biosynthesis creates novel possibilities for manipulating NAD+ biosynthetic pathways, which is key for the future of therapeutics. NAD+ biosynthesis is an attractive and promising therapeutic target for influencing health span and obesity-related phenotypes as well as tumor growth. Full and effective use of this target for therapeutic benefit requires a complete understanding of NAD+ biosynthetic pathways. Here, we report a previously unrecognized role for a conserved phosphoribosyltransferase in NAD+ biosynthesis. Because a required quinolinic acid phosphoribosyltransferase (QPRTase) is not encoded in its genome, Caenorhabditis elegans are reported to lack a de novo NAD+ biosynthetic pathway. However, all the genes of the kynurenine pathway required for quinolinic acid (QA) production from tryptophan are present. Thus, we investigated the presence of de novo NAD+ biosynthesis in this organism. By combining isotope-tracing and genetic experiments, we have demonstrated the presence of an intact de novo biosynthesis pathway for NAD+ from tryptophan via QA, highlighting the functional conservation of this important biosynthetic activity. Supplementation with kynurenine pathway intermediates also boosted NAD+ levels and partially reversed NAD+-dependent phenotypes caused by mutation of pnc-1, which encodes a nicotinamidase required for NAD+ salvage biosynthesis, demonstrating contribution of de novo synthesis to NAD+ homeostasis. By investigating candidate phosphoribosyltransferase genes in the genome, we determined that the conserved uridine monophosphate phosphoribosyltransferase (UMPS), which acts in pyrimidine biosynthesis, is required for NAD+ biosynthesis in place of the missing QPRTase. We suggest that similar underground metabolic activity of UMPS may function in other organisms. This mechanism for NAD+ biosynthesis creates novel possibilities for manipulating NAD+ biosynthetic pathways, which is key for the future of therapeutics." @default.
• W2617221282 created "2017-06-05" @default.
• W2617221282 creator A5006816270 @default.
• W2617221282 creator A5009535270 @default.
• W2617221282 creator A5031138415 @default.
• W2617221282 creator A5040130837 @default.
• W2617221282 date "2017-07-01" @default.
• W2617221282 modified "2023-10-14" @default.
• W2617221282 title "Uridine monophosphate synthetase enables eukaryotic de novo NAD+ biosynthesis from quinolinic acid" @default.
• W2617221282 cites W1770620752 @default.
• W2617221282 cites W1924255629 @default.
• W2617221282 cites W1944127002 @default.
• W2617221282 cites W1994124478 @default.
• W2617221282 cites W2008249034 @default.
• W2617221282 cites W2019394625 @default.
• W2617221282 cites W2030219469 @default.
• W2617221282 cites W2061816256 @default.
• W2617221282 cites W2064316112 @default.
• W2617221282 cites W2075010970 @default.
• W2617221282 cites W2093048027 @default.
• W2617221282 cites W2114382609 @default.
• W2617221282 cites W2120276500 @default.
• W2617221282 cites W2130973560 @default.
• W2617221282 cites W2141796595 @default.
• W2617221282 cites W2143015660 @default.
• W2617221282 cites W2153528954 @default.
• W2617221282 cites W2164072059 @default.
• W2617221282 cites W3145751116 @default.
• W2617221282 cites W4238473188 @default.
• W2617221282 doi "https://doi.org/10.1074/jbc.c117.795344" @default.
• W2617221282 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5500784" @default.
• W2617221282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28559281" @default.
• W2617221282 hasPublicationYear "2017" @default.
• W2617221282 type Work @default.
• W2617221282 sameAs 2617221282 @default.
• W2617221282 citedByCount "15" @default.
• W2617221282 countsByYear W26172212822018 @default.
• W2617221282 countsByYear W26172212822019 @default.
• W2617221282 countsByYear W26172212822020 @default.
• W2617221282 countsByYear W26172212822021 @default.
• W2617221282 countsByYear W26172212822022 @default.
• W2617221282 countsByYear W26172212822023 @default.
• W2617221282 crossrefType "journal-article" @default.
• W2617221282 hasAuthorship W2617221282A5006816270 @default.
• W2617221282 hasAuthorship W2617221282A5009535270 @default.
• W2617221282 hasAuthorship W2617221282A5031138415 @default.
• W2617221282 hasAuthorship W2617221282A5040130837 @default.
• W2617221282 hasBestOaLocation W26172212821 @default.
• W2617221282 hasConcept C104317684 @default.
• W2617221282 hasConcept C143065580 @default.
• W2617221282 hasConcept C181199279 @default.
• W2617221282 hasConcept C192989942 @default.
• W2617221282 hasConcept C194101687 @default.
• W2617221282 hasConcept C2776901170 @default.
• W2617221282 hasConcept C2777991568 @default.
• W2617221282 hasConcept C2780391879 @default.
• W2617221282 hasConcept C512185932 @default.
• W2617221282 hasConcept C553450214 @default.
• W2617221282 hasConcept C55493867 @default.
• W2617221282 hasConcept C75520062 @default.
• W2617221282 hasConcept C78179603 @default.
• W2617221282 hasConcept C86803240 @default.
• W2617221282 hasConceptScore W2617221282C104317684 @default.
• W2617221282 hasConceptScore W2617221282C143065580 @default.
• W2617221282 hasConceptScore W2617221282C181199279 @default.
• W2617221282 hasConceptScore W2617221282C192989942 @default.
• W2617221282 hasConceptScore W2617221282C194101687 @default.
• W2617221282 hasConceptScore W2617221282C2776901170 @default.
• W2617221282 hasConceptScore W2617221282C2777991568 @default.
• W2617221282 hasConceptScore W2617221282C2780391879 @default.
• W2617221282 hasConceptScore W2617221282C512185932 @default.
• W2617221282 hasConceptScore W2617221282C553450214 @default.
• W2617221282 hasConceptScore W2617221282C55493867 @default.
• W2617221282 hasConceptScore W2617221282C75520062 @default.
• W2617221282 hasConceptScore W2617221282C78179603 @default.
• W2617221282 hasConceptScore W2617221282C86803240 @default.
• W2617221282 hasFunder F4320337544 @default.
• W2617221282 hasIssue "27" @default.
• W2617221282 hasLocation W26172212821 @default.
• W2617221282 hasLocation W26172212822 @default.
• W2617221282 hasLocation W26172212823 @default.
• W2617221282 hasOpenAccess W2617221282 @default.
• W2617221282 hasPrimaryLocation W26172212821 @default.
• W2617221282 hasRelatedWork W1218434330 @default.
• W2617221282 hasRelatedWork W1515164389 @default.
• W2617221282 hasRelatedWork W2040047628 @default.
• W2617221282 hasRelatedWork W2041243532 @default.
• W2617221282 hasRelatedWork W2073624634 @default.
• W2617221282 hasRelatedWork W2393553660 @default.
• W2617221282 hasRelatedWork W2991470517 @default.
• W2617221282 hasRelatedWork W3143988383 @default.
• W2617221282 hasRelatedWork W4254900740 @default.
• W2617221282 hasRelatedWork W2503208303 @default.
• W2617221282 hasVolume "292" @default.
• W2617221282 isParatext "false" @default.
• W2617221282 isRetracted "false" @default.
• W2617221282 magId "2617221282" @default.
• W2617221282 workType "article" @default.